News

From 4th to 8th October 2025, our specialists had the honor of participating in the EANM 2025 Annual Congress in […]

Every year on October 15th, we pay special attention to the topic of breast cancer – a disease that affects […]

Nowadays, medical facilities face an ever-growing challenge: to provide patients with swift, comprehensive and welcoming care at every stage of […]

With a commitment to patient health and to facilitating access to specialized medical care, our facility has introduced the option […]

Radelumin is a modern radiopharmaceutical that has gained recognition in recent years for the diagnosis of prostate cancer. Registered and […]

On June 24, 2025, the BioSkaner team (LOMiRT) in Białystok became the first in the Podlaskie Voivodeship to administer a […]

On April 28, 2025, a conference was held at the Białystok Science and Technology Park to mark the 10th anniversary […]

Radiopharmaceuticals are medicinal products that, when ready for use, are labeled with at least one isotope emitting ionizing radiation. Additionally, […]

The BioSkaner Laboratory, operated by the Molecular Imaging and Technology Development Laboratory Ltd., is a modern facility that is an […]

BioSkaner, which has received the prestigious EARL 18F Standard 1 and 2 accreditation for the Siemens Biograph mMR PET/MR scanner, […]

Technological advancements in medicine, particularly in the field of diagnostic imaging, have revolutionized the way we detect and monitor cancer […]

“Patient’s well-being is our goal” – this motto has guided all activities of the Molecular Imaging and Technology Development Laboratory […]